NFGC - Supported Publications from 2004

1. Howard B, Zheng Z, Champa M, Wang M, Sharma A, Haura E, Herndon J, Fitzgerald M, Bepler G, Patz E. Translating biomarkers into clinical practice: prognostic implications of CyPA and MIF identified from protein expression profiles in non-small cell lung cancer. Lung Cancer. 2004 Dec; 46(3):313-23. PMID: 15541816 (Tissue Procurement Core).
2. Epling-Burnette P, Bai F, Wei S, Chaurasia P, Painter J, Olashaw N, Hamilton A, Sebti S, Djeu J, Loughran T. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene. 2004 Dec 9; 23(57):9220-9. PMID: 15516985 (Drug Discovery Core).
3. Ma Y, Freeman SN, and Cress WD. E2F4 Deficiency Promotes Drug-Induced Apoptosis. Cancer Biology and Therapy. 2004 Dec 3; 1262-1269. PMID: 15611646 (Cress Pilot Project).
4. Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J, Sebti S, Chellappan S. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol. 2004 Nov; 24(21):9527-41. PMID: 15485920 (Analytic Microscopy Core).
5. Li L, Tang H, Wu Z, Gong J, Gruidl M, Zou J, Tockman M, Clark R. Data mining techniques for cancer detection using serum proteomic profiling. Artif Intell Med. 2004 Oct; 32(2)71-83. PMID: 15364092 (Proteomics Core).
6. Eschrich S, Yeatman TJ. DNA microarrays and data analysis: an overview. Surgery. 2004 Sep; 136(3):500-3. PMID: 15349092 (Biostatistics Core).
7. Dasgupta P, Betts V, Rastogi S, Joshi B, Morris M, Brennan B, Ordonez-Ercan D, Chellappan S. Direct binding of apoptosis signal-regulating kinase 1 to retinoblastomaprotein: novel links between apoptotic signaling and cell cycle machinery. J Biol Chem. 2004 Sep 10; 279(37):38762-9. Epub 2004 Jun 21. PMID: 15210709 (Molecular Biology Core and Analytic Microscopy Core).
8. George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, Moscinski L, Bhalla K. Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. Cancer Res. 2004 May 15; 64(10):3645-52. PMID: 15150124 (Analytic Microscopy Core).
9. Berchuck A, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, Marks JR.  Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol. 2004 Apr; 190(4):910-25. PMID: 15118612 (Lancaster Pilot Project).
10. Gyory I, Wu J, Fejer G, Seto E, Wright K. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol. 2004 Mar; 5(3):299-308. Epub 2004 Feb 22. PMID: 14985713 (Molecular Biology Core).
11. Bloom G, Yang I, Boulware D, Kwong KY, Coppola D, Eschrich S. Quackenbush Classification. American Journal of Pathology. 2004 Jan; 164(1):9-16. PMID: 14695313 (Biomedical Informatics Core).
    
    Page edited 06/10/09